skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » Regular Columns » AIM Round-up » AIM round-up: Angle, Caspian Sunrise, Atlantic Lithium

London’s AIM market has spent the bulk of the day underwater, but losses by the closing bell were limited to less than two points, leaving the junior index at 953.45

  • Angle +58%
  • Caspian Sunrise +41%
  • Atlantic Lithium +16%
  • Randall & Quilter -39%
  • Morses Club -35%

Angle [LON:AGL] was the day’s best performer, adding 58% by the closing bell. This morning the company announced that it had received FDA clearance for its Parsortix system, a major validation which is expected to fuel commercial growth for the medtech firm. The process involves harvesting and analysing cancel cells from blood samples, offering the prospect of a new era of personalised cancer care.

Caspian Sunrise [LON:CASP] also fared well, adding 41% in the wake of an operational update. A successful re-drilling operation has added a further 1400bpd to production and the company now plans to repeat this approach at other sites.

Atlantic Lithium [LON:ALL] gets the notable mention, up 16%. Following media speculation, the company issued a statement this morning confirming that Ghana’s Minerals Income Investment Fund is considering making a potential investment in the business.

Randall & Quilter [LON:RQIH] found itself at the bottom of the board today, down some 39% off the back of a spat with its potential acquirer. They have stated that R&Q is in breach of certain obligations, which could cause the takeover to fail and with it rule out $100m worth of equity investment.

Morses Club [LON:MCL] also struggled, off 35% in the wake of a full year results update, noting that numbers for the 12 months to February 26th, which were due to be released this month will now be held over until August. Investors appear to have taken flight off the back of this news, with the company’s update back in February, cautioning over the volume of claims being filed against the business, taking on an extra layer of gravitas.


Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we are following most closely. They all represent significant growth stories in our view. Our in-depth reports go into more detail on why we like them.


Subscribe for more stories like this, 8am weekdays - for free!

Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
Back To Top